• Je něco špatně v tomto záznamu ?

Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions

D. Cibula, WG. McCluggage,

. 2019 ; 152 (1) : 202-207. [pub] 20181011

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012265

Grantová podpora
NV16-31643A MZ0 CEP - Centrální evidence projektů

Sentinel lymph node (SLN) biopsy has been increasingly used in the management of early-stages cervical cancer instead of systematic pelvic lymph node dissection (PLND). The aim of this article is to give a critical overview of key aspects related to this concept, such as a necessity for reliable detection of micrometastases (MIC) in SLN and the requirements for SLN pathologic ultrastaging, low accuracy of intraoperative detection of SLN involvement, and still a limited evidence of oncological safety of the replacement of PLND by SLN biopsy only in ≥IB1 tumours due to unknown risk of MIC in non-SLN pelvic lymph nodes in patients with negative SLN, and absence of any prospective evidence.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012265
003      
CZ-PrNML
005      
20190411132219.0
007      
ta
008      
190405s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ygyno.2018.10.007 $2 doi
035    __
$a (PubMed)30318103
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cibula, David $u Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic. Electronic address: dc@davidcibula.cz.
245    10
$a Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions / $c D. Cibula, WG. McCluggage,
520    9_
$a Sentinel lymph node (SLN) biopsy has been increasingly used in the management of early-stages cervical cancer instead of systematic pelvic lymph node dissection (PLND). The aim of this article is to give a critical overview of key aspects related to this concept, such as a necessity for reliable detection of micrometastases (MIC) in SLN and the requirements for SLN pathologic ultrastaging, low accuracy of intraoperative detection of SLN involvement, and still a limited evidence of oncological safety of the replacement of PLND by SLN biopsy only in ≥IB1 tumours due to unknown risk of MIC in non-SLN pelvic lymph nodes in patients with negative SLN, and absence of any prospective evidence.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lymfadenektomie $7 D008197
650    _2
$a mikrometastázy $7 D061206
650    _2
$a prognóza $7 D011379
650    _2
$a sentinelová uzlina $x patologie $7 D000071036
650    _2
$a nádory děložního čípku $x patologie $x chirurgie $7 D002583
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a McCluggage, W Glenn $u Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom.
773    0_
$w MED00001958 $t Gynecologic oncology $x 1095-6859 $g Roč. 152, č. 1 (2019), s. 202-207
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30318103 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411132236 $b ABA008
999    __
$a ok $b bmc $g 1391575 $s 1050570
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 152 $c 1 $d 202-207 $e 20181011 $i 1095-6859 $m Gynecologic oncology $n Gynecol Oncol $x MED00001958
GRA    __
$a NV16-31643A $p MZ0
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...